Joseph H. Capper
President and Chief Executive Officer
Joe Capper was appointed President and Chief Executive Officer of CardioNet in June 2010 and now serves in that same capacity for BioTelemetry. Prior to CardioNet, Joe served as President, Chief Executive Officer and member of the Board of Directors of Home Diagnostics, Inc., a leading developer, manufacturer and marketer of diabetes management products. Joe joined Home Diagnostics in 2009 and positioned the Company for a strategic merger in a transaction that created substantial value to its stakeholders. Home Diagnostics was listed on the NASDAQ stock market until its strategic merger.
Prior to Home Diagnostics, Joe was President and Chief Executive Officer of CCS Medical Inc., a private company that is a leading provider of medical supplies in diabetes, wound care, respiratory and other therapeutic categories. During Joe’s tenure as Chief Executive Officer, he built the Company into one of the largest providers of diabetes and respiratory testing supplies for Medicare beneficiaries and the private insured. During this time, the Company’s revenue grew from $60 million to over $500 million through organic growth and acquisitions.
Earlier in his career, Joe spent nine years with Bayer Corporation, ultimately becoming National Sales Director of the Diabetic Products Division where he led a 180-person sales organization with responsibility for over $350 million in revenue. Joe also has a distinguished service record having served in the U.S. Navy as a combat aviator and subsequently as a Congressional Liaison. Joe received his undergraduate degree in Accounting from West Chester University and an MBA in International Finance from George Washington University.
Heather Getz, CPA
Chief Financial Officer
Senior Vice President, Sales and Marketing
Andy Broadway joined CardioNet in June 2009, bringing nearly 15 years of pharmaceutical sales and marketing experience, including extensive therapeutic knowledge in Cardiology and Neurology. Most recently, Andy was Director of Marketing at Bristol-Myers Squibb, leading the commercialization launch efforts of a potential new therapy for the treatment of Stroke Prevention in Atrial Fibrillation. Prior to Bristol-Myers Squibb, Andy was on the marketing team at Pfizer, where he led the development of the strategic vision, brand platform evolution, commercialization of new clinical studies, and launch of new indications for several leading brands. Andy started his career with Sanofi Pharmaceuticals, where he held numerous positions of increasing responsibility including sales, specialty sales, sales management, and marketing management. Andy received his undergraduate degree in Zoology from Auburn University.
Wayne M. Derkac, M.D.
Vice President, Medical Affairs
Dr. Derkac joined BioTelemetry after a career practicing cardiothoracic surgery initially at Massachusetts General Hospital in Boston, MA and subsequently serving as President of Mid-Atlantic Cardiothoracic Surgeons at Sentara Heart Hospital in Norfolk, VA. He received his surgical training at Massachusetts General and Boston Children’s Hospital and was a Clinical Associate in the Surgery Branch, NHLBI at the National Institutes of Health in Bethesda, Maryland. Dr. Derkac attended Dartmouth College and received his M.D. from the Columbia University College of Physicians and Surgeons (AOA).
General Counsel and Senior Vice President, Corporate Development
Peter Ferola joined CardioNet in February 2011, with more than 19 years of progressive leadership experience in business management, legal affairs and corporate governance. Most recently, Peter served as Vice President, General Counsel and Secretary at Nipro Diagnostics, Inc. (formerly Home Diagnostics, Inc). Prior to joining Nipro Diagnostics, Peter worked as a corporate and securities attorney with Greenberg Traurig, LLP and with Dilworth Paxson, LLP in Washington, D.C., focusing on mergers, acquisitions, public securities offerings, and corporate governance matters. From 1989 to 2002, Peter worked in executive management roles for an American Stock Exchange-listed company, including serving as Vice President, Administration and Corporate Secretary, overseeing the company’s administrative functions, legal matters, and investor relations. Peter received a Bachelor of Science and Juris Doctor degree from Nova Southeastern University and a Master of Laws in Securities and Financial Regulation from Georgetown University Law Center.